2026-09-17 23:53:55 UTC / 路透社
作者：格拉姆·斯莱特里
2026年9月17日 世界协调时23:53，16分钟前更新
- 摘要
- 该检测于9月初暂停后，将恢复针对30岁及以上美国军人的检测
- 美国国防部长赫格塞特表示，筛查有助于提升战斗准备状态
- 医疗专业人员警告，不当使用睾酮可能增加不孕风险
华盛顿9月17日路透电 — 五角大楼一名发言人周四表示，美国国防部将重启针对30岁及以上美军人员的睾酮缺乏强制检测项目，这一被众多医学专家称为不必要且可能有害的项目将重新启动。
此前大力推广使用睾酮以提升军队战备状态的美国国防部长皮特·赫格塞特于今年7月首次宣布了这项强制筛查政策。
订阅屡获殊荣的路透社健康快报，随时了解最新医学突破与医疗保健趋势。点击此处注册。
广告 · 滚动继续阅读
根据已公布的指导方案，女性也将通过问卷形式接受筛查，之后可针对激素失衡相关病症接受治疗。
但在9月初，五角大楼临时撤销了已发布的睾酮筛查医疗指导方案，“以进行更新完善”。
此次最新举措解除了暂停令，允许检测工作继续推进。目前尚不清楚原政策是否进行了任何修改，若有修改的话具体修改内容是什么。
五角大楼发言人肖恩·帕内尔在一份声明中表示：“该指导方案即日起生效，将针对男性睾酮缺乏问题建立统一的筛查和治疗路径。”
广告 · 滚动继续阅读
医疗专业人员此前曾警告，若不当开具睾酮处方，可能会增加军人的不孕风险或引发其他健康问题。
Item 1 of 2 2026年9月9日摄于美国马萨诸塞州梅尔罗斯，一盒可供一个月使用的睾酮凝胶。艾米·斯旺 供图/路透社 本图片由第三方提供/档案照片
[1/2]2026年9月9日摄于美国马萨诸塞州梅尔罗斯，一盒可供一个月使用的睾酮凝胶。艾米·斯旺 供图/路透社 本图片由第三方提供/档案照片 购买授权 打开新标签页
blob:https://www.reuters.com/fbb9a09d-c1f5-481b-82da-8a2726dc5f2a
本报道由格拉姆·斯莱特里采写；杰米·弗里德编辑
我们的报道准则：汤森路透信托原则。
Pentagon to proceed with controversial testosterone testing after pause
2026-09-17 23:53:55 UTC / Reuters
By Gram Slattery
September 17, 2026 11:53 PM UTC Updated 16 mins ago
- Summary
- Testing resumes for US servicemembers age 30 and older after early September pause
- US Defense Secretary Hegseth says screenings could improve battle readiness
- Medical professionals warn inappropriate testosterone use could raise infertility risk
WASHINGTON, Sept 17 (Reuters) – The Pentagon is reinstituting a mandatory testing program for testosterone deficiency among US service members age 30 and older, a spokesperson said on Thursday, bringing back a program that many medical experts have described as unnecessary and potentially harmful.
US Defense Secretary Pete Hegseth, who has promoted the use of testosterone to improve military readiness, first announced the screening mandate in July.
Keep up with the latest medical breakthroughs and healthcare trends with the award-winning Reuters Health Rounds newsletter. Sign up here.
Advertisement · Scroll to continue
Under the announced guidance, women were also set to be screened through a questionnaire and could then move to treatment for conditions related to hormonal imbalances.
In early September, however, the Pentagon temporarily rescinded the published medical guidance for the testosterone screening “to allow for updates.”
The latest move lifts that pause, allowing testing to go forward. It was not immediately clear what, if any, updates had been made to the original policy.
“Effective immediately, this guidance addresses male testosterone deficiency, establishing uniform screening and treatment pathways,” Pentagon spokesperson Sean Parnell said in a statement.
Advertisement · Scroll to continue
Medical professionals have warned that testosterone, if prescribed inappropriately, could increase service members’ risk of infertility or lead to other health consequences.
Item 1 of 2 A month’s supply of testosterone gel is displayed in its box in Melrose, Massachusetts, U.S., September 9, 2026. Amy Swan/Handout via REUTERS THIS IMAGE HAS BEEN SUPPLIED BY A THIRD PARTY/File Photo
[1/2]A month’s supply of testosterone gel is displayed in its box in Melrose, Massachusetts, U.S., September 9, 2026. Amy Swan/Handout via REUTERS THIS IMAGE HAS BEEN SUPPLIED BY A THIRD PARTY/File Photo Purchase Licensing Rights, opens new tab
blob:https://www.reuters.com/fbb9a09d-c1f5-481b-82da-8a2726dc5f2a
Reporting by Gram Slattery; Editing by Jamie Freed
Our Standards: The Thomson Reuters Trust Principles.
发表回复